An Immune Microenvironment-Integrated Intestinal-on-a-Chip Model for Investigating Immunopathogenesis in Inflammatory Bowel Disease
Molecules · 2026
DOI: 10.3390/molecules31091520 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Shiyang Ying und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Microelectronics, Shanghai University, Shanghai 200444, China. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Lab-On-A-Chip Devices, Intestinal Mucosa, Cellular Microenvironment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, CAS-NSTDA, CAS-NSTDA Joint Research Project.
Abstract (Originalsprache)
Owing to the multifactorial nature of inflammatory bowel disease (IBD) pathogenesis, conventional two-dimensional (2D) models inadequately recapitulate the complex in vivo microenvironment. This study sought to develop an immune-microenvironment-integrated intestinal-on-a-chip model to overcome these limitations. A microfluidic chip was engineered to co-culture intestinal epithelial (Caco-2) cells and macrophages, facilitating the simulation of IBD pathological conditions for mechanistic investigations. Following inflammatory stimulation, M0 macrophages polarized into the M1 phenotype, concomitant with the upregulation of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1 beta (IL-1β). This induction disrupted the expression of tight junction proteins (e.g., zonula occludens-1 [ZO-1]) in Caco-2 cells, thereby compromising epithelial barrier integrity. Infliximab was used as a model drug to inhibit TNF-α and modulate macrophage polarization within the chip, effectively rescuing impaired epithelial barrier integrity. This study establishes a reliable intestinal-on-a-chip model that recapitulates macrophage–epithelial interactions in IBD, providing a robust platform for elucidating the mechanisms underlying intestinal barrier dysfunction and developing targeted therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Microelectronics, Shanghai University, Shanghai 200444, China.
- State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
- Shanghai Institute of Microsystem and Information Technology, Chinese Academy of Sciences, Shanghai 200050, China.
- School of Physics and Optoelectronic Engineering, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- Human Phenome Institute, Fudan University, Shanghai 200438, China.
Förderung
- State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine
- CAS-NSTDA
- CAS-NSTDA Joint Research Project
- Program of State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine
Zitieren
APA
Ying, S., Xu, H., Xu, Y., & Mi, X. (2026). An Immune Microenvironment-Integrated Intestinal-on-a-Chip Model for Investigating Immunopathogenesis in Inflammatory Bowel Disease. Molecules. https://doi.org/10.3390/molecules31091520
Vancouver
Ying S, Xu H, Xu Y, Mi X. An Immune Microenvironment-Integrated Intestinal-on-a-Chip Model for Investigating Immunopathogenesis in Inflammatory Bowel Disease. Molecules. 2026. doi:10.3390/molecules31091520
BibTeX
@article{Ying2026,
author = {Ying, Shiyang and Xu, Huanhua and Xu, Yi and Mi, Xianqiang},
title = {An Immune Microenvironment-Integrated Intestinal-on-a-Chip Model for Investigating Immunopathogenesis in Inflammatory Bowel Disease},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31091520}
}
EUVIMED